Literature DB >> 15582154

DeltaFosB: a molecular switch for long-term adaptation in the brain.

Colleen A McClung1, Paula G Ulery, Linda I Perrotti, Venetia Zachariou, Olivier Berton, Eric J Nestler.   

Abstract

DeltaFosB is a unique transcription factor that plays an essential role in long-term adaptive changes in the brain associated with diverse conditions, such as drug addiction, Parkinson's disease, depression, and antidepressant treatment. It is induced in brain, in a region- and cell-type-specific manner by many types of chronic perturbations. Once induced, it persists for long periods of time due to its unusual stability. The transcriptional effects of DeltaFosB are complex, because the protein can function as both a transcriptional activator and repressor. Progress has been made in identifying specific target genes for DeltaFosB and in relating some of these genes to DeltaFosB's cellular and behavioral actions. Future studies will help us to better understand the biochemical basis of DeltaFosB's unique stability, as well as the precise molecular pathways through which this transcription factor produces its complex effects on neuronal plasticity and complex behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582154     DOI: 10.1016/j.molbrainres.2004.05.014

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  159 in total

1.  Exposure of adolescent mice to 3,4-methylenedioxypyrovalerone increases the psychostimulant, rewarding and reinforcing effects of cocaine in adulthood.

Authors:  R López-Arnau; M A Luján; L Duart-Castells; D Pubill; J Camarasa; O Valverde; E Escubedo
Journal:  Br J Pharmacol       Date:  2017-04-06       Impact factor: 8.739

2.  Differential regulation of c-Fos and FosB in the rat brain after amygdala kindling.

Authors:  Torsten M Madsen; Tom G Bolwig; Jens D Mikkelsen
Journal:  Cell Mol Neurobiol       Date:  2006-02       Impact factor: 5.046

3.  Epigenetics of nicotine: another nail in the coughing.

Authors:  Nora D Volkow
Journal:  Sci Transl Med       Date:  2011-11-02       Impact factor: 17.956

4.  An Essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia.

Authors:  J Thomas Cunningham; W David Knight; Steven W Mifflin; Eric J Nestler
Journal:  Hypertension       Date:  2012-06-11       Impact factor: 10.190

Review 5.  The leucine-rich repeat superfamily of synaptic adhesion molecules: LRRTMs and Slitrks.

Authors:  Jaewon Ko
Journal:  Mol Cells       Date:  2012-07-04       Impact factor: 5.034

6.  ΔFosB in the nucleus accumbens is critical for reinforcing effects of sexual reward.

Authors:  K K Pitchers; K S Frohmader; V Vialou; E Mouzon; E J Nestler; M N Lehman; L M Coolen
Journal:  Genes Brain Behav       Date:  2010-08-16       Impact factor: 3.449

7.  Comparison of ΔFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants.

Authors:  Havan Furmaga; Mohona Sadhu; Alan Frazer
Journal:  J Pharmacol Exp Ther       Date:  2012-01-27       Impact factor: 4.030

8.  Impaired activation of CA3 pyramidal neurons in the epileptic hippocampus.

Authors:  Giuseppe Biagini; Giovanna D'Arcangelo; Enrica Baldelli; Margherita D'Antuono; Virginia Tancredi; Massimo Avoli
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

9.  Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia.

Authors:  Hiroko Nomaru; Kunihiko Sakumi; Atsuhisa Katogi; Yoshinori N Ohnishi; Kosuke Kajitani; Daisuke Tsuchimoto; Eric J Nestler; Yusaku Nakabeppu
Journal:  Glia       Date:  2014-04-25       Impact factor: 7.452

10.  Knockdown of tyrosine hydroxylase in the nucleus of the solitary tract reduces elevated blood pressure during chronic intermittent hypoxia.

Authors:  Chandra Sekhar Bathina; Anuradha Rajulapati; Michelle Franzke; Kenta Yamamoto; J Thomas Cunningham; Steve Mifflin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-18       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.